Johnson & Johnson Vision Care, Inc. v. 1-800 Contacts, Inc.

299 F.3d 1242, 2002 U.S. App. LEXIS 15462, 2002 WL 1747896
CourtCourt of Appeals for the Eleventh Circuit
DecidedJuly 29, 2002
Docket02-10322
StatusPublished
Cited by180 cases

This text of 299 F.3d 1242 (Johnson & Johnson Vision Care, Inc. v. 1-800 Contacts, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Johnson & Johnson Vision Care, Inc. v. 1-800 Contacts, Inc., 299 F.3d 1242, 2002 U.S. App. LEXIS 15462, 2002 WL 1747896 (11th Cir. 2002).

Opinion

BIRCH, Circuit Judge:

In this interlocutory appeal, 1-800 CONTACTS, Inc. (“1-800”) argues that the district court erred when it issued a preliminary injunction forbidding 1-800 from making certain statements about the products and services of Johnson & Johnson Vision , Care, Inc. (“J&J”). The district court based its 'injunction on the conclusion that three of the advertisements used by 1-800 included false statements about J&J, and as such violated § 43(a) of the Lan-ham Act, codified at 15 U.S.C. 1125(a). 1 *1246 Because we conclude that the district court erred in applying the law, we VACATE the preliminary injunction, and REMAND.

I. BACKGROUND

Both J&J and 1-800 are in the contact lens business. J&j manufactures lenses, including those under the well-known ACUVUE ® brand; 1-800 sells lenses, including ACUVUE, over the phone and the internet. J&J argues that three of 1-800’s advertisements make statements about J&J or about ACUVUE that are literally false. The first advertisement at issue is a letter sent by 1-800 to its customers recommending CIBA Vision’s Focus Dailies, a 1-day lens, over J&J’s ACU-VUE, a 2-week lens. In this letter (the “Focus Dailies letter”), 1-800 cites a study published by a trade journal named Contact Lens Spectrum (“CLS study”) which identified a five to one consumer preference for Focus Dailies over ACUVUE. The second advertisement, also a letter, was sent by 1-800 to customers who requested J&J lenses that were not in stock at the time of the customer’s order. This letter (the “Exclusive Deal letter”) explains that 1-800’s inability to process the customer’s order was due to J&J’s policy of distributing contacts exclusively to eye doctors, rather than to retailers like 1-800. The third advertisement is a four-page pamphlet about Focus Dailies (the “Focus Dailies pamphlet”) that was sent out with the Exclusive Deal letter. The pamphlet cites the five to one preference for Focus Dailies and compares the qualities of the lens against those of “competing lenses.” Rl-33, Ex. G at 3.

J&J brought suit against 1-800, alleging false advertising under § 43(a) of Lanham Act and under multiple state law provisions across the country. J&J moved for a preliminary injunction, which the district court granted. 1-800 now appeals the injunction.

II. DISCUSSION.

Only if the district court abused its discretion will we reverse the grant of a preliminary injunction. Am. Bd. of Psychiatry & Neurology, Inc. v. Johnson-Powell, 129 F.3d 1, 2-3 (1st Cir.1997). We review the district court’s findings of fact under the clearly erroneous standard. Id. at 3. The facts found by a district court are “clearly erroneous when, although there is evidence to support it, the reviewing court on the entire evidence is left with the definite and firm conviction that a mistake has been committed.” Univ. of Georgia Athletic Ass’n v. Laite, 756 F.2d 1535 (11th Cir.1985) (internal quotations omitted). The clearly erroneous standard is appropriate in cases, such as this one, in which the evidence is primarily documentary; the fact that the district court’s decision was not a function of credibility determinations does not affect the standard of review. Anderson v. City of Bessemer City, 470 U.S. 564, 574, 105 S.Ct. 1504, 1511-12, 84 L.Ed.2d 518 (1985). Lastly, our review of the district court’s application of law is de novo, premised on the understanding that “[application of an improper legal standard ... is never within a district court’s discretion.” Johnson-Powell, 129 F.3d at 3.

For a district court to grant a preliminai-y injunction, the movant must establish: (1) a substantial likelihood of success on the merits of the underlying case, (2) the movant will suffer irreparable harm in the absence of an injunction, (3) the harm suffered by the movant in the *1247 absence of an injunction would exceed the harm suffered by the opposing party if the injunction issued, and (4) an injunction would not disserve the public interest. Carillon Imp., Ltd. v. Frank Pesce Int’l Group Ltd., 112 F.3d 1125, 1126 (11th Cir.1997) (per curiam). To establish the likelihood of success on the merits of a false advertising claim under § 43(a) of the Lanham Act, 15 U.S.C. § 1125(a), the mov-ant must establish: (1) the ads of the opposing party were false or misleading, (2) the ads deceived, or had the capacity to deceive, consumers, (3) the deception had a material effect on purchasing decisions,. (4) the misrepresented product or service affects interstate commerce, and (5) the movant has been—or is likely to be—injured as a result of the false advertising. ALPO Petfoods, Inc. v. Ralston Purina Co., 913 F.2d 958, 964 (D.C.Cir.1990). If the movant is unable to establish a likelihood of success on the merits, a court need not consider the remaining conditions prerequisite to injunctive relief. Pittman v. Cole, 267 F.3d 1269, 1292 (11th Cir.2001).

Our analysis begins and ends with the five elements J&J needed to establish the likelihood of success. First, J&J needed to prove that 1-800’s ads were false or misleading. This element is satisfied if the challenged advertisement is literally false, or if the challenged advertisement is literally true, but misleading. Johnson & Johnson * Merck Consumer Pharms. Co. v. Smithkline Beecham Corp., 960 F.2d 294, 297 (2d Cir.1992). It is clear that the district court found each of the three advertisements to be either false or misleading, but it is unclear into which category the court placed the ads. 2

The category is relevant; once a court deems an advertisement to be literally false, the movant need not present evidence of consumer deception. Am. Council of Certified Podiatric Physicians and Surgeons v. Am. Bd. of Podiatric Surgery, Inc., 185 F.3d 606, 614 (6th Cir.1999). If the court deems an ad to be true but misleading, the movant—even at the preliminary injunction stage—must present evidence of deception. 3

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Select Comfort Corporation v. John Baxter
996 F.3d 925 (Eighth Circuit, 2021)
Ethicon, Inc. v. Laura Angelini
687 F. App'x 859 (Eleventh Circuit, 2017)
Gravelle v. Kaba Ilco Corporation
684 F. App'x 974 (Federal Circuit, 2017)
VeriSign, Inc. v. XYZ.COM LLC
848 F.3d 292 (Fourth Circuit, 2017)
Commodores Entertainment Corporation v. Thomas McClary
648 F. App'x 771 (Eleventh Circuit, 2016)
Merck Eprova AG v. Brookstone Pharmaceuticals, LLC
920 F. Supp. 2d 404 (S.D. New York, 2013)
Melissa C. Cross v. The Quality Management Group, LLC
491 F. App'x 53 (Eleventh Circuit, 2012)
Suntree Technologies, Inc. v. Ecosense International, Inc.
802 F. Supp. 2d 1273 (M.D. Florida, 2011)
National Organization for Marriage v. Roberts
753 F. Supp. 2d 1217 (N.D. Florida, 2010)
Miller's Ale House, Inc. v. Boynton Carolina Ale House, LLC
745 F. Supp. 2d 1359 (S.D. Florida, 2010)
Federal Express Corp. v. United Parcel Service, Inc.
765 F. Supp. 2d 1011 (W.D. Tennessee, 2010)
Osmose, Inc. v. Viance, LLC
Eleventh Circuit, 2010
QVC, Inc. v. Your Vitamins, Inc.
714 F. Supp. 2d 291 (D. Delaware, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
299 F.3d 1242, 2002 U.S. App. LEXIS 15462, 2002 WL 1747896, Counsel Stack Legal Research, https://law.counselstack.com/opinion/johnson-johnson-vision-care-inc-v-1-800-contacts-inc-ca11-2002.